FDA OKs SynCardia trial for bridge-to-transplant indication

SynCardia says the FDA approved a clinical trial of its artificial heart as a bridge to transplant for patients with heart failure.

SynCardia Systems said today that it won FDA approval for a clinical trial of its artificial heart as a bridge to transplant for patients with heart failure.

Food & Drug Administration (FDA), SynCardia

News Well, Clinical Trials, Cardiac Assist Devices

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1OUIzuj